All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Enlargement | NCIT_C73432 | [The act of increasing (something) in size or volume or quantity or scope.] |
| Cubic Foot | NCIT_C48487 | [A traditional unit of volume equal to 1728 cubic inches, or 1/27 cubic yard, or 0.028 316 85 cubic meter (28.316 85 liters). The cubic foot holds about 7.4805 US gallons.] |
| Capsule Dosing Unit | NCIT_C48480 | [A dosing unit equal to the amount of active ingredient(s) contained in a capsule.] |
| Cartridge Dosing Unit | NCIT_C48481 | [A dosing unit equal to the amount of active ingredient(s) contained in a cartridge.] |
| Clinical Unit | NCIT_C48482 | [The amount of a substance required to achieve a specified, measurable physiological change in a controlled environment.] |
| Coat Dosing Unit | NCIT_C48483 | [A dosing measurement based on the coat unit.] |
| Apgar Score | NCIT_C73437 | [The numerical sum between zero and ten that is computed from individual values of zero to two that are assigned to five different areas of interest in newborn screenings. These areas are breathing, muscle tone, pulse rate, reflex irritability and skin color.] |
| Belagenpumatucel-L | NCIT_C73438 | [A transforming growth factor beta2 (TGF-beta2) antisense gene-modified allogeneic tumor cell vaccine with potential immunostimulatory and antineoplastic activities. Belagenpumatucel-L is prepared by transfecting allogeneic non-small cell lung cancer (NSCLC) cells with a plasmid containing a TGF-beta2 antisense transgene, expanding the cells, and then irradiating and freezing them. Upon administration, this agent may elicit a cytotoxic T lymphocyte (CTL) response against host NSCLC cells, resulting in decreased tumor cell proliferation; vaccine immunogenicity may be potentiated by suppression of tumor TGF-beta2 production by antisense RNA expressed by the vaccine plasmid TGF-beta2 antisense transgene. Elevated levels of TGF-beta2 are frequently linked to immunosuppression in cancer patients and may be inversely correlated with prognosis in patients with NSCLC.] |
| Axial | NCIT_C73439 | [Situated on or along or in the direction of an axis.] |
| KLF4 wt Allele | NCIT_C73450 | [Human KLF4 wild-type allele is located in the vicinity of 9q31 and is approximately 5 kb in length. This allele, which encodes Krueppel-like factor 4 protein, is involved in the modulation of transcription.] |
| 9q31 | NCIT_C13604 | [A chromosome band present on 9q] |
| Bottle Dosing Unit | NCIT_C48477 | [A dosing unit equal to the amount of active ingredient(s) contained in a bottle.] |
| NKX2-1 wt Allele | NCIT_C73444 | [Human NKX2-1 wild-type allele is located in the vicinity of 14q13 and is approximately 4 kb in length. This allele, which encodes thyroid transcription factor 1 protein, is involved in the modulation of transcription for thyroid specific genes and may play a role in lung development. Mutations in the gene are associated with hypothyroidism, neonatal respiratory distress, and both benign hereditary chorea and choreoathetosis.] |
| NKX2-1 Gene | NCIT_C73443 | [This gene plays a role in thyroid gene transcription.] |
| Box Dosing Unit | NCIT_C48478 | [A dosing unit equal to the amount of active ingredient(s) contained in a box.] |
| Thyroid Transcription Factor 1 | NCIT_C73445 | [Thyroid transcription factor 1 (371 aa, ~39 kDa) is encoded by the human NKX2-1 gene. This protein is involved in transcriptional regulation.] |
| Can Dosing Unit | NCIT_C48479 | [A dosing unit equal to the amount of active ingredient(s) contained in a can.] |
| PSMB9 Gene | NCIT_C73446 | [This gene is involved in the mediation of antigen processing during non-lysosomal protein catabolism.] |
| PSMB9 wt Allele | NCIT_C73447 | [Human PSMB9 wild-type allele is located in the vicinity of 6p21.3 and is approximately 6 kb in length. This allele, which encodes proteasome subunit beta type-9 protein, plays a role in the regulation of the catabolism of proteins to generate class I major histocompatibility complex antigens.] |
| Ampule Dosing Unit | NCIT_C48473 | [A dosing unit equal to the amount of active ingredient(s) contained in an ampule.] |